<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p116" style="overflow: hidden; position: relative; background-color: white; width: 908px; height: 1286px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_116{left:130px;bottom:1195px;letter-spacing:0.2px;}
#t2_116{left:796px;bottom:1195px;letter-spacing:0.13px;}
#t3_116{left:238px;bottom:1115px;letter-spacing:-0.01px;}
#t4_116{left:238px;bottom:1096px;letter-spacing:-0.01px;}
#t5_116{left:238px;bottom:1076px;letter-spacing:-0.01px;}
#t6_116{left:238px;bottom:1057px;letter-spacing:-0.01px;}
#t7_116{left:238px;bottom:1037px;letter-spacing:-0.01px;}
#t8_116{left:238px;bottom:970px;letter-spacing:-0.01px;}
#t9_116{left:238px;bottom:950px;letter-spacing:-0.01px;}
#ta_116{left:238px;bottom:931px;letter-spacing:-0.01px;}
#tb_116{left:712px;bottom:931px;letter-spacing:-0.01px;}
#tc_116{left:238px;bottom:912px;letter-spacing:-0.01px;}
#td_116{left:238px;bottom:892px;letter-spacing:-0.01px;}
#te_116{left:238px;bottom:825px;letter-spacing:-0.01px;}
#tf_116{left:238px;bottom:805px;letter-spacing:-0.01px;}
#tg_116{left:238px;bottom:786px;letter-spacing:-0.01px;}
#th_116{left:238px;bottom:766px;letter-spacing:-0.01px;}
#ti_116{left:128px;bottom:698px;letter-spacing:-0.19px;}
#tj_116{left:238px;bottom:698px;letter-spacing:-0.2px;}
#tk_116{left:141px;bottom:658px;letter-spacing:-0.01px;}
#tl_116{left:248px;bottom:659px;letter-spacing:0.25px;}
#tm_116{left:143px;bottom:601px;letter-spacing:-0.29px;}
#tn_116{left:250px;bottom:621px;letter-spacing:-0.01px;}
#to_116{left:250px;bottom:602px;letter-spacing:-0.01px;}
#tp_116{left:250px;bottom:582px;letter-spacing:-0.01px;}
#tq_116{left:248px;bottom:547px;letter-spacing:-0.04px;}
#tr_116{left:141px;bottom:481px;letter-spacing:-0.01px;}
#ts_116{left:248px;bottom:482px;letter-spacing:0.25px;}
#tt_116{left:143px;bottom:425px;letter-spacing:-0.29px;}
#tu_116{left:250px;bottom:445px;letter-spacing:-0.01px;}
#tv_116{left:250px;bottom:425px;letter-spacing:-0.01px;}
#tw_116{left:248px;bottom:370px;letter-spacing:-0.04px;}
#tx_116{left:141px;bottom:305px;letter-spacing:-0.01px;}
#ty_116{left:248px;bottom:306px;letter-spacing:0.25px;}
#tz_116{left:143px;bottom:248px;letter-spacing:-0.29px;}
#t10_116{left:250px;bottom:268px;letter-spacing:-0.01px;}
#t11_116{left:250px;bottom:249px;letter-spacing:-0.01px;}
#t12_116{left:248px;bottom:213px;letter-spacing:0.09px;}
#t13_116{left:238px;bottom:159px;letter-spacing:-0.01px;}
#t14_116{left:202px;bottom:69px;letter-spacing:0.23px;}

.s0_116{font-size:11px;font-family:NotoSans-Regular_7j-;color:#000;}
.s1_116{font-size:12px;font-family:NotoSans-Regular_7j-;color:#000;}
.s2_116{font-size:13px;font-family:NotoSans-Regular_7j-;color:#000;}
.s3_116{font-size:18px;font-family:NotoSans-Regular_7j-;color:#000;}
.s4_116{font-size:28px;font-family:NotoSans-Regular_7j-;color:#000;}
.s5_116{font-size:10px;font-family:NotoSans-Regular_7j-;color:#000;}
.s6_116{font-size:9px;font-family:NotoSans-Regular_7j-;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts116" type="text/css" >

@font-face {
	font-family: NotoSans-Regular_7j-;
	src: url("fonts/NotoSans-Regular_7j-.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg116Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg116" style="-webkit-user-select: none;"><object width="908" height="1286" data="116/116.svg" type="image/svg+xml" id="pdf116" style="width:908px; height:1286px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_116" class="t s0_116">7.11. Palliative therapy </span><span id="t2_116" class="t s1_116">116 </span>
<span id="t3_116" class="t s2_116">Palliative medicine/palliative care aims to improve or maintain the quality of life of patients with </span>
<span id="t4_116" class="t s2_116">a life-threatening illness and their families. This is done by preventing and alleviating suffering, </span>
<span id="t5_116" class="t s2_116">by early recognition and treatment of physical, psychological, social and spiritual problems </span>
<span id="t6_116" class="t s2_116">[408]. Palliative medicine/palliative care affirms life and sees dying as a natural process; it </span>
<span id="t7_116" class="t s2_116">neither accelerates it nor delays death [409]. </span>
<span id="t8_116" class="t s2_116">Palliative medicine and palliative care are used as a general term for all activities aimed at </span>
<span id="t9_116" class="t s2_116">improving the quality of life of people with incurable, life-threatening (cancer) diseases and </span>
<span id="ta_116" class="t s2_116">emphasize the interdisciplinary and multi-professional nature of this area of </span><span id="tb_116" class="t s2_116">care. Palliative </span>
<span id="tc_116" class="t s2_116">medicine is therefore not reduced to the medical and/or physician contribution, but is </span>
<span id="td_116" class="t s2_116">understood comprehensively in the sense of multi-professional palliative care. </span>
<span id="te_116" class="t s2_116">Patients at the end of their lives and their relatives are accompanied – at home, in palliative </span>
<span id="tf_116" class="t s2_116">care day clinics and in inpatient hospices. </span>
<span id="tg_116" class="t s2_116">Multiprofessional teams work together to provide care that is tailored to individual needs and </span>
<span id="th_116" class="t s2_116">choices, while striving for dignity, peace and tranquility [406, 409]. </span>
<span id="ti_116" class="t s3_116">7.11.1. </span><span id="tj_116" class="t s3_116">Palliative systemic drug treatment </span>
<span id="tk_116" class="t s2_116">7.78. </span><span id="tl_116" class="t s0_116">Consensus-based recommendation </span>
<span id="tm_116" class="t s4_116">EEC </span>
<span id="tn_116" class="t s2_116">If the general condition is adequate (= ECOG 0 to 2), patients with recurrence or metastasis </span>
<span id="to_116" class="t s2_116">should receive palliative systemic therapy after all locoregional curative treatment options </span>
<span id="tp_116" class="t s2_116">(surgery or radiotherapy) have been exhausted. </span>
<span id="tq_116" class="t s5_116">Strong consensus: 100% </span>
<span id="tr_116" class="t s2_116">7.79. </span><span id="ts_116" class="t s0_116">Consensus-based recommendation </span>
<span id="tt_116" class="t s4_116">EEC </span>
<span id="tu_116" class="t s2_116">As palliative chemotherapy, platinum (preferably cisplatin) and 5-FU in combination with </span>
<span id="tv_116" class="t s2_116">cetuximab should be given in first-line therapy in good general condition (= ECOG 0 to 1). </span>
<span id="tw_116" class="t s5_116">Strong consensus: 100% </span>
<span id="tx_116" class="t s2_116">7.80. </span><span id="ty_116" class="t s0_116">Consensus-based recommendation </span>
<span id="tz_116" class="t s4_116">EEC </span>
<span id="t10_116" class="t s2_116">In first-line therapy, systemic monotherapy can be given or best supportive care can be </span>
<span id="t11_116" class="t s2_116">offered from ECOG 2 onwards. </span>
<span id="t12_116" class="t s6_116">Consensus: 91% </span>
<span id="t13_116" class="t s2_116">In ECOG 2, an individual treatment decision should be made [410]. </span>
<span id="t14_116" class="t s0_116">© Oncology Guideline Program | S3 Guideline Laryngeal Carcinoma | Long Version 1.0 | January 2019 </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
